SEC Form 4 · accession 0001209191-16-109872
ANTARES PHARMA, INC. · ATRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert P Roche Jr.
Director
Period of report
Mar 18, 2016
Accepted (ET)
Mar 22, 2016 · 8:58 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001016169
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 18, 2016 | P | 50,000 | $0.72 | A | 88,172 | D |
Table II — derivative securities
No Table II lines on this filing.